Hohl Benjamin

Enliven Therapeutics, Inc. ยท CHIEF FINANCIAL OFFICER

Hohl Benjamin is listed in public filings as officer: CHIEF FINANCIAL OFFICER. This Hohl Benjamin insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Enliven Therapeutics, Inc. (ELVN). Investors use Hohl Benjamin's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Enliven Therapeutics, Inc.ELVN$1.5M51k sharesSellMar 6, 2026$295.8K10k shares$29.58--

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Enliven Therapeutics, Inc.ELVN$4.1M150k sharesGrant / ExerciseFeb 12, 2026$4.1M150k shares$27.16--
Enliven Therapeutics, Inc.ELVN--61k sharesGrant / ExerciseFeb 12, 2026Disclosure amount unavailable25k shares----
Enliven Therapeutics, Inc.ELVN$89k36k sharesGrant / ExerciseDec 22, 2025$32.2K13k shares$2.48--
Enliven Therapeutics, Inc.ELVN$469k23k sharesSellSep 29, 2025$66.3K3.3k shares$20.40--
Enliven Therapeutics, Inc.ELVN$65k26.3k sharesGrant / ExerciseSep 29, 2025$8.1K3.3k shares$2.48--
Enliven Therapeutics, Inc.ELVN$474k23k sharesSellAug 27, 2025$67.0K3.3k shares$20.63--
Enliven Therapeutics, Inc.ELVN$65k26.3k sharesGrant / ExerciseAug 27, 2025$8.1K3.3k shares$2.48--
Enliven Therapeutics, Inc.ELVN$490k23k sharesSellJul 28, 2025$1.4K65 shares$21.30--
Enliven Therapeutics, Inc.ELVN$472k23.1k sharesSellJul 28, 2025$65.1K3.2k shares$20.45--
Enliven Therapeutics, Inc.ELVN$65k26.3k sharesGrant / ExerciseJul 28, 2025$8.1K3.3k shares$2.48--
Enliven Therapeutics, Inc.ELVN$60k24k sharesGrant / ExerciseJul 10, 2025$2.5K1k shares$2.48--
Enliven Therapeutics, Inc.ELVN$521k23k sharesSellJul 10, 2025$22.7K1k shares$22.66--
Enliven Therapeutics, Inc.ELVN$498k23k sharesSellJun 27, 2025$4.3K198 shares$21.66--
Enliven Therapeutics, Inc.ELVN$484k23.2k sharesSellJun 27, 2025$63.7K3.1k shares$20.86--
Enliven Therapeutics, Inc.ELVN$65k26.3k sharesGrant / ExerciseJun 27, 2025$8.1K3.3k shares$2.48--
Enliven Therapeutics, Inc.ELVN$519k23k sharesSellJun 13, 2025$67.7K3k shares$22.55--
Enliven Therapeutics, Inc.ELVN$64k26k sharesGrant / ExerciseJun 13, 2025$7.4K3k shares$2.48--
Enliven Therapeutics, Inc.ELVN$372k23k sharesSellMay 27, 2025$52.6K3.3k shares$16.18--
Enliven Therapeutics, Inc.ELVN$65k26.3k sharesGrant / ExerciseMay 27, 2025$8.1K3.3k shares$2.48--
Enliven Therapeutics, Inc.ELVN$440k23k sharesSellApr 28, 2025$1.3K69 shares$19.12--
Enliven Therapeutics, Inc.ELVN$431k23.1k sharesSellApr 28, 2025$59.4K3.2k shares$18.68--
Enliven Therapeutics, Inc.ELVN$65k26.3k sharesGrant / ExerciseApr 28, 2025$8.1K3.3k shares$2.48--
Enliven Therapeutics, Inc.ELVN$491k23k sharesSellMar 27, 2025$69.3K3.3k shares$21.33--
Enliven Therapeutics, Inc.ELVN$65k26.3k sharesGrant / ExerciseMar 27, 2025$8.1K3.3k shares$2.48--
Enliven Therapeutics, Inc.ELVN$60k24k sharesGrant / ExerciseMar 24, 2025$2.5K1k shares$2.48--
Enliven Therapeutics, Inc.ELVN$518k23k sharesSellMar 24, 2025$22.5K1k shares$22.50--
Enliven Therapeutics, Inc.ELVN$57k23k sharesGrant / ExerciseMar 4, 2025$24.8K10k shares$2.48--
Enliven Therapeutics, Inc.ELVN$265k13k sharesSellFeb 27, 2025$66.3K3.3k shares$20.41--
Enliven Therapeutics, Inc.ELVN$40k16.3k sharesGrant / ExerciseFeb 27, 2025$8.1K3.3k shares$2.48--
Enliven Therapeutics, Inc.ELVN$3.8M171k sharesGrant / ExerciseFeb 6, 2025$3.8M171k shares$22.47--
Enliven Therapeutics, Inc.ELVN$35k14k sharesGrant / ExerciseFeb 5, 2025$2.5K1k shares$2.48--
Enliven Therapeutics, Inc.ELVN$293k13k sharesSellFeb 5, 2025$22.5K1k shares$22.52--
Enliven Therapeutics, Inc.ELVN$281k13k sharesSellJan 27, 2025$70.2K3.3k shares$21.59--
Enliven Therapeutics, Inc.ELVN$40k16.3k sharesGrant / ExerciseJan 27, 2025$8.1K3.3k shares$2.48--
Enliven Therapeutics, Inc.ELVN$35k14k sharesGrant / ExerciseJan 3, 2025$2.5K1k shares$2.48--
Enliven Therapeutics, Inc.ELVN$326k13k sharesSellJan 3, 2025$25.0K1k shares$25.04--
Enliven Therapeutics, Inc.ELVN$2.2k900 sharesGrant / ExerciseDec 30, 2024$2.2K900 shares$2.48--
Enliven Therapeutics, Inc.ELVN$0900 sharesSellDec 30, 2024$20.3K900 shares$22.51--
Enliven Therapeutics, Inc.ELVN$03.4k sharesSellDec 27, 2024$74.2K3.4k shares$22.15--
Enliven Therapeutics, Inc.ELVN$8.3k3.4k sharesGrant / ExerciseDec 27, 2024$8.3K3.4k shares$2.48--
Enliven Therapeutics, Inc.ELVN$32k13k sharesGrant / ExerciseDec 13, 2024$32.2K13k shares$2.48--
Enliven Therapeutics, Inc.ELVN$25k1k sharesSellNov 27, 2024$105.3K4.3k shares$24.78--
Enliven Therapeutics, Inc.ELVN$01k sharesSellNov 27, 2024$25.4K1k shares$25.38--
Enliven Therapeutics, Inc.ELVN$13k5.3k sharesGrant / ExerciseNov 27, 2024$13.0K5.3k shares$2.48--
Enliven Therapeutics, Inc.ELVN$19k650 sharesSellOct 28, 2024$159.6K5.6k shares$28.49--
Enliven Therapeutics, Inc.ELVN$0650 sharesSellOct 28, 2024$18.9K650 shares$29.11--
Enliven Therapeutics, Inc.ELVN$16k6.3k sharesGrant / ExerciseOct 28, 2024$15.5K6.3k shares$2.48--
Enliven Therapeutics, Inc.ELVN$2.0k814 sharesGrant / ExerciseOct 18, 2024$2.0K814 shares$2.48--
Enliven Therapeutics, Inc.ELVN$0814 sharesSellOct 18, 2024$24.4K814 shares$30.00--
Enliven Therapeutics, Inc.ELVN$5.0k2k sharesGrant / ExerciseOct 7, 2024$3.1K1.3k shares$2.48--
Enliven Therapeutics, Inc.ELVN$01.3k sharesSellOct 7, 2024$34.9K1.3k shares$27.51--
Enliven Therapeutics, Inc.ELVN$010.2k sharesSellOct 4, 2024$281.1K10.2k shares$27.51--
Enliven Therapeutics, Inc.ELVN$25k10.2k sharesGrant / ExerciseOct 4, 2024$25.3K10.2k shares$2.48--
Enliven Therapeutics, Inc.ELVN$1.3k521 sharesGrant / ExerciseOct 1, 2024$1.3K521 shares$2.48--
Enliven Therapeutics, Inc.ELVN$0521 sharesSellOct 1, 2024$14.3K521 shares$27.54--
Enliven Therapeutics, Inc.ELVN$5.0k2k sharesGrant / ExerciseSep 30, 2024$5.0K2k shares$2.48--
Enliven Therapeutics, Inc.ELVN$02k sharesSellSep 30, 2024$50.7K2k shares$25.33--
Enliven Therapeutics, Inc.ELVN$04.3k sharesSellSep 27, 2024$103.2K4.3k shares$24.27--
Enliven Therapeutics, Inc.ELVN$11k4.3k sharesGrant / ExerciseSep 27, 2024$10.5K4.3k shares$2.48--
Enliven Therapeutics, Inc.ELVN$04.3k sharesSellAug 27, 2024$95.8K4.3k shares$22.54--
Enliven Therapeutics, Inc.ELVN$11k4.3k sharesGrant / ExerciseAug 27, 2024$10.5K4.3k shares$2.48--
Enliven Therapeutics, Inc.ELVN$2.5k991 sharesGrant / ExerciseJul 31, 2024$2.5K991 shares$2.48--
Enliven Therapeutics, Inc.ELVN$0991 sharesSellJul 31, 2024$27.3K991 shares$27.53--
Enliven Therapeutics, Inc.ELVN$061 sharesSellJul 29, 2024$1.7K61 shares$27.44--
Enliven Therapeutics, Inc.ELVN$1.6k61 sharesSellJul 29, 2024$138.4K5.2k shares$26.67--
Enliven Therapeutics, Inc.ELVN$13k5.3k sharesGrant / ExerciseJul 29, 2024$13.0K5.3k shares$2.48--
Enliven Therapeutics, Inc.ELVN$03k sharesSellJul 12, 2024$75.2K3k shares$25.07--
Enliven Therapeutics, Inc.ELVN$7.4k3k sharesGrant / ExerciseJul 12, 2024$7.4K3k shares$2.48--
Enliven Therapeutics, Inc.ELVN$26k1.1k sharesSellJun 27, 2024$41.3K1.8k shares$22.58--
Enliven Therapeutics, Inc.ELVN$65k3k sharesSellJun 27, 2024$27.9K1.3k shares$21.79--
Enliven Therapeutics, Inc.ELVN$01.1k sharesSellJun 27, 2024$26.7K1.1k shares$23.43--
Enliven Therapeutics, Inc.ELVN$11k4.3k sharesGrant / ExerciseJun 27, 2024$10.5K4.3k shares$2.48--